Event submissions
Published
This submission belongs to the session A. ECMC-3 of the event 3rd International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2017
Citation
Emília Sousa, Andreia Palmeira, Madalena Pinto, Ivanna Hrynchak, Ana Reis-Mendes, Maria Lourdes Bastos, Vera Costa, Old Pharmaceuticals with New Applications: the Case Studies of Lucanthone and Mitoxantrone, in Proceedings of 3rd International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2017, MDPI: Basel, Switzerland, doi: 10.3390/ecmc-3-04663
Share
Email
Facebook
Twitter
LinkedIn
Old Pharmaceuticals with New Applications: the Case Studies of Lucanthone and Mitoxantrone
'%3e%3cpath%20d='M12.6647%2010.9104C12.4176%2010.325%2012.0589%209.7933%2011.6088%209.34485C11.16%208.89511%2010.6283%208.53653%2010.0432%208.28891C10.038%208.28629%2010.0327%208.28498%2010.0275%208.28236C10.8437%207.69282%2011.3743%206.73252%2011.3743%205.64907C11.3743%203.85423%209.92005%202.40002%208.12522%202.40002C6.33038%202.40002%204.87618%203.85423%204.87618%205.64907C4.87618%206.73252%205.40677%207.69282%206.22296%208.28367C6.21772%208.28629%206.21248%208.2876%206.20724%208.29022C5.62031%208.53783%205.09365%208.89287%204.64167%209.34616C4.19192%209.79496%203.83334%2010.3266%203.58573%2010.9117C3.34247%2011.4846%203.21128%2012.0987%203.19925%2012.721C3.1989%2012.735%203.20135%2012.7489%203.20646%2012.7619C3.21157%2012.7749%203.21924%2012.7868%203.22901%2012.7968C3.23877%2012.8068%203.25045%2012.8148%203.26334%2012.8202C3.27623%2012.8256%203.29007%2012.8284%203.30406%2012.8284H4.09012C4.14776%2012.8284%204.19362%2012.7825%204.19493%2012.7262C4.22113%2011.7148%204.62726%2010.7676%205.34519%2010.0497C6.08802%209.30686%207.07452%208.89811%208.12522%208.89811C9.17592%208.89811%2010.1624%209.30686%2010.9052%2010.0497C11.6232%2010.7676%2012.0293%2011.7148%2012.0555%2012.7262C12.0568%2012.7839%2012.1027%2012.8284%2012.1603%2012.8284H12.9464C12.9604%2012.8284%2012.9742%2012.8256%2012.9871%2012.8202C13%2012.8148%2013.0117%2012.8068%2013.0214%2012.7968C13.0312%2012.7868%2013.0389%2012.7749%2013.044%2012.7619C13.0491%2012.7489%2013.0515%2012.735%2013.0512%2012.721C13.0381%2012.0947%2012.9084%2011.4856%2012.6647%2010.9104ZM8.12522%207.90243C7.52388%207.90243%206.95792%207.66793%206.53214%207.24215C6.10636%206.81636%205.87185%206.2504%205.87185%205.64907C5.87185%205.04773%206.10636%204.48177%206.53214%204.05599C6.95792%203.63021%207.52388%203.3957%208.12522%203.3957C8.72655%203.3957%209.29252%203.63021%209.7183%204.05599C10.1441%204.48177%2010.3786%205.04773%2010.3786%205.64907C10.3786%206.2504%2010.1441%206.81636%209.7183%207.24215C9.29252%207.66793%208.72655%207.90243%208.12522%207.90243Z'%20fill='%235D1EE1'/%3e%3c/g%3e%3c/svg%3e)
Ivanna Hrynchak 1
Ana Reis-Mendes 2
Andreia Palmeira 1
Maria Lourdes Bastos 2
Madalena Pinto 1,3
Vera Costa 2
Emília Sousa 1,3
1. a Laboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Portugal
2. Requimte, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal
3. b Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), University of Porto, Portugal
Abstract
Keywords
existing drugs
mitoxantrone
lucanthone
metabolites
anticancer
Manuscript
ecmc-3-ppt_esousa_2017.pdf
Poster
ecmc-3-ppt_esousa_2017.pdf